Questionnaires Designed to Assess Knowledge of Heart Failure Patients: A Systematic Review.

BACKGROUND: The objectives of this systematic review were (1) to describe the psychometric properties of questionnaires designed to assess knowledge of heart failure (HF) patients and (2) to identify the most applicable questionnaire to assess knowledge of HF patients. METHODS: A literature search of electronic databases was conducted from database inception to March 2014. Eligible articles included studies describing the development and psychometric testing of questionnaires designed to assess HF patients' knowledge. Outcomes were based on the quality criteria for measurement properties of health status questionnaires. Articles were considered for inclusion by 2 authors independently. RESULTS: Overall, 12 articles were included, of which 4 (33.33%) were considered "good" quality. Twelve original English-language instruments were identified. Content validity was described in 10 studies and presented positive ratings in all of them (83.33%); internal consistency in 10 studies and positive ratings in 5 (41.66%); construct validity in 5 and positive ratings in 4 (33.33%); responsiveness in 3 and positive ratings in 2 (16.66%); and reproducibility and floor effects in 1 with positive ratings. Based on our criteria, the Atlanta HF Knowledge Test was identified as the most applicable questionnaire to assess knowledge of HF patients. CONCLUSION: Psychometric properties of questionnaires assessing HF patients' knowledge are poorly described in the literature. Although we identified the Atlanta HF Knowledge Test as the most promising instrument, it has methodological limitations. We recommend the researchers to use the questionnaire that best serves their research question and context.

Information about secondary prevention in coronary patients: a comparison between Italian and Brazilian application of MICRO-Q questionnaire.

BACKGROUND: The MICRO-Q (Maugerl CaRdiac preventiOn Questionnaire) is a self-administered questionnaire addressed to the evaluation of information regarding secondary prevention in patients with coronary heart disease (CHD). The aim of this study was to compare the results from Italian and Brazilian application of MICRO-Q. METHODS: the instrument was administered to 500 coronary patients (250 Italian and 250 Brazilian), 117 female and 383 male, aged on average 61.16 years (SD = 9.74; range: 33-86), participants of cardiac rehabilitation programs. The Italian MICRO-Q has 26 items, 18 true statements and 8 false, with responses true, false and 'don't know', with three separate scores: correct, uncorrect and uncertain. The Brazilian MICRO-Q has 25 items, 18 true statements and 7 false, with the same responses and scores. To verify and compare results we used Independent-Sample T Test, ANOVA and Bonferroni Post-hoc. RESULTS: The analysis of mean total scores of Italian and Brazilian applications showed statistically significant differences for correct answers (p < 0.001) and for 'don't know' answers (p < 0.001). 18 statements had significant (p < 0.005) differences between applications in the two countries. CONCLUSION: Despite differences between Italy and Brazil, the analysis of MICRO-Q applications showed a similar mean score percent of correct answers, indicating enough knowledge about secondary prevention of CHD.

Maintenance of Gains, Morbidity, and Mortality at 1 Year Following Cardiac Rehabilitation in a Middle-Income Country: A Wait-List Control Crossover Trial.

Background Despite the epidemic of cardiovascular diseases in middle-income countries, few trials are testing the benefits of cardiac rehabilitation ( CR ). This trial assessed (1) maintenance of functional capacity, risk factor control, knowledge, and heart-health behaviors and (2) mortality and morbidity at 6 months following CR in a middle-income country. Methods and Results Eligible Brazilian coronary patients were initially randomized (1:1:1 concealed) to 1 of 3 parallel arms (comprehensive CR [exercise plus education], exercise-only CR , or wait-list control). The CR programs were 6 months in duration, at which point follow-up assessments were performed. Mortality and morbidity were ascertained from chart and patient or family report (blinded). Controls were then offered CR (crossover). Outcomes were again assessed 6 months later (blinded). ANCOVA was performed for each outcome at 12 months. Overall, 115 (88.5%) patients were randomized, and 62 (53.9%) were retained at 1 year. At 6 months, 23 (58.9%) of those 39 initially randomized to the wait-list control elected to attend CR . Functional capacity, risk factors, knowledge, and heart-health behaviors were maintained from 6 to 12 months in participants from both CR arms (all P>0.05). At 1 year, knowledge was significantly greater with comprehensive CR at either time point ( P<0.001). There were 2 deaths. Hospitalizations ( P=0.03), nonfatal myocardial infarctions ( P=0.04), and percutaneous coronary interventions ( P=0.03) were significantly fewer with CR than control at 6 months. Conclusions CR participation is associated with lower morbidity, long-term maintenance of functional capacity, risk factors, and heart-health behaviors, as well as with greater cardiovascular knowledge compared with no CR . Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 02575976.

Cardiac Rehabilitation Models around the Globe.

Alternative models of cardiac rehabilitation (CR) delivery, such as home or community-based programs, have been developed to overcome underutilization. However, their availability and characteristics have never been assessed globally. In this cross-sectional study, a piloted survey was administered online to CR programs globally. CR was available in 111/203 (54.7%) countries globally; data were collected in 93 (83.8% country response rate). 1082 surveys (32.1% program response rate) were initiated. Globally, 85 (76.6%) countries with CR offered supervised programs, and 51 (45.9%; or 25.1% of all countries) offered some alternative model. Thirty-eight (34.2%) countries with CR offered home-based programs, with 106 (63.9%) programs offering some form of electronic CR (eCR). Twenty-five (22.5%) countries with CR offered community-based programs. Where available, programs served a mean of 21.4% ± 22.8% of their patients in home-based programs. The median dose for home-based CR was 3 sessions (Q25-Q75 = 1.0⁻4.0) and for community-based programs was 20 (Q25⁻Q75 = 9.6⁻36.0). Seventy-eight (47.0%) respondents did not perceive they had sufficient capacity to meet demand in their home-based program, for reasons including funding and insufficient staff. Where alternative CR models are offered, capacity is insufficient half the time. Home-based CR dose is insufficient to achieve health benefits. Allocation to program model should be evidence-based.